Table S1-17 (Discovering novel antigenic peptides targeted cervical cancer by profiling HLA-I ligandomes)

Table S1 The clinical profiles of twenty-one CC patients.Table S2 PC HLA-I peptides source proteins.Table S3 CC HLA-I peptides source proteins.Table S4 tumor-associated proteins in UniProtKB database.Table S5 CC-exclusive HLA-I peptides source proteins.Table S6 The diseases associated with GPX1.Table S7 The diseases associated with CKAP5.Table S8 The diseases associated with MYO9B.Table S9 The diseases associated with LAMB1.Table S10 The diseases associated with MCM4.Table S11 The diseases associated with EIF3D.Table S12 The diseases associated with PNKP.Table S13 The other 54 cervical cancer patients in this study.Table S14 PD-1 expression observed in healthy donors.Table S15 The information regarding the twelve peptides.Table S16 The characteristics of nine healthy donors.Table S17 The affinity prediction result of peptide “AKKGGEKKKG”.